The questionable efficacy of pirfenidone in IPF [1]

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 9, 2005, Pages 1228-

  Mathai, Stephen C ^a   Polito, Albert J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIRFENIDONE;

CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; EXERCISE TEST; HUMAN; HYPOXEMIA; LETTER; LUNG FIBROSIS; PRIORITY JOURNAL; RANDOMIZATION; TREATMENT OUTCOME;

EID: 30344461322     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/ajrccm.172.9.950     Document Type: Letter

References (3)

1. Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, Taguchi Y, Nagai S, Itoh H, Ohi M, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:1040-1047.
2. Piantadosi S. Clinical trials: a methodologic perspective. New York: John Wiley & Sons; 1997.
3. Slutsky AS, Lavery JV. Data safety and monitoring boards. N Engl J Med 2004;350:1143-1147.